Jpmorgan Chase & CO Lexaria Bioscience Corp. Transaction History
Jpmorgan Chase & CO
- $1.1 Trillion
- Q1 2024
Shares
1 transactions
Others Institutions Holding LEXX
# of Institutions
26Shares Held
889KCall Options Held
0Put Options Held
0-
Invenomic Capital Management LP Boston, MA473KShares$1.32 Million0.09% of portfolio
-
Geode Capital Management, LLC Boston, MA99.3KShares$276,1590.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA85.2KShares$236,7330.0% of portfolio
-
Raymond James Financial Services Advisors, Inc. St. Petersburg, FL39.6KShares$109,9480.0% of portfolio
-
State Street Corp Boston, MA39.3KShares$109,2560.0% of portfolio
About Lexaria Bioscience Corp.
- Ticker LEXX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 5,951,000
- Market Cap $16.5M
- Description
- Lexaria Bioscience Corp. operates as a biotechnology company. Its patented drug delivery technology, DehydraTECH, improves the way active pharmaceutical ingredients enter the bloodstream by promoting effective oral delivery. The company's DehydraTECH has demonstrated the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x ...